April's Annals of Thoracic Surgery issue will feature a study led by Alexandra Potter on #lungcancerscreening eligibility in the Boston Lung Cancer Study: authors.elsevier.com/a/1koSaovKl3dU Only 46% of patients with #lungcancer were eligible to get screened under current USPSTF guidelines.

Our next two Together Separately livestreams focus on different #LungCancer patient populations: young people and women. Join us and these experts, along with moderator Dr. Isabel Preeshagul! Isabel Preeshagul Wed, April 23, 4pm ET: Young Lung Cancer with Dr. Eric Singhi Eric K. Singhi, MD,

How did we get so lucky to feature these two power houses in a row Eric K. Singhi, MD and Narjust Florez, MD, FASCO ! Topics include - young lung cancer and screening - sexual health and lung cancer - why are the rates of lung cancer increasing in women? Much more! #lcsm

My 27-year-old son with autism didn’t ‘destroy our family’—he gave us purpose and unity… oh, and he pays taxes.

Holly Robinson-Peete’s 27 year old son RJ is autistic and she has used her platform to become one of the most visible advocates for the autism community. She reacts to RFK Jr’s horrible and inaccurate comments about autism here. Holly Robinson Peete 💃🏾♍️

RFK Jr. “These kids [with autism] will never play baseball.” *My boy in the batter’s box hitting .372 stimming like an absolute demon*

Women have unique challenges when facing a #LungCancer diagnosis. Drs. Narjust Florez and Isabel Preeshagul will address them during our May 14 Together Separately livestream, Women and Lung Cancer. Join us at 4 pm ET - sign up at LCRF.org/together. #WomenLC Isabel Preeshagul

LCRF's science team talked about #AACR25 and our grantees who presented work there last week. Here's a sneak preview – watch the full conversation at LCRF.org/25sp. #LungCancer #ResearchIsOurTrueNorth

Since our very first event in 2019, Libby’s Lungs has raised over $375,000 (as of Dec. 2024) for groundbreaking research and patient support at UPMC Hillman Cancer Center — and we’re just getting started. 💪 As we proudly celebrate our second year as an independent nonprofit, we

Tumor testing to identify #biomarkers can determine the most effective treatment. Insist that your cancer is tested for the best outcomes. Learn more at LCRF.org/biomarkers. #LungCancer

Congratulations to Dr. Jeff Yang from the Division of Thoracic Surgery who has been selected by Harvard Medical School as a recipient of their 2025 Young Mentor Award for 2025! Dr. Yang will be celebrated at a reception on June 3, 2025, at Harvard Medical School

Preserving funding for cancer research is a nonpartisan issue. Lend your voice to the fight to restore #lungcancerresearch funding. #lcsm Link in thread.

Add your voice to this campaign! nwmd.social/s/twitter/4AqA…

Three years ago today, I had absolutely no idea what had just hit me. Stage 4 ALK Positive Lung Cancer at just 35 years of age? What on earth was that? Even now, I’m not sure I have better answers. I’ve learned to navigate this so-called “new normal,” but let’s be honest—it’s

LCRF is excited to announce the expansion of its Research Advocates. This select group of volunteers helps shape LCRF’s research priorities and includes patients, survivors, caregivers, healthcare professionals, and advocates committed to identifying and funding innovative

Critical reminder that ANYONE w/ lungs can get lung cancer. We need more research & need to develop a pathway to screen high risk never smokers. Lung Cancer Research Foundation ACS National Lung Cancer Roundtable American Cancer Society LUNGevity Foundation American Thoracic Society (ATS) AATS The Society of Thoracic Surgeons ASCO ESMO - Eur. Oncology CDMRP Charles Swanton National Cancer Institute

LCRF is pleased to announce a new research collaboration with Boehringer Ingelheim Boehringer Ingelheim, creating two funding mechanisms to address HER2 mutations in #LungCancer: a new Team Science Award and an Early Career Investigator Award. Read more about these research grants here:

We’ve joined forces with Lung Cancer Research Foundation on a #research collaboration to further understand and treat #lungcancer with HER2 mutations. Learn more: prn.to/3ZX8MUv

"Living with cancer is not the same as surviving cancer. It’s a distinction that needs to be acknowledged and understood, and research needs to reflect this reality." - Jill Feldman

Pleased to see that Dr. Stabile will be speaking to LiveLung this week. Libby’s Lungs is proud to support her research.